Ayushman Bharat: Tele-consultation facility to start at 1 lakh wellness centres from Saturday

New DelhiTele-consultation facility ‘e-Sanjeevani’ will start at 1 lakh Ayushman Bharat-Health and Wellness Centres (AB-HWCs) from April 16, Union Health Minister Mansukh Mandaviya said on Friday. Mandaviya had chaired a virtual meeting on Tuesday with health ministers and senior officials of all the states and union territories to review the operationalisation status of AB-HWCs and tele-consultation services.

“Now common citizens will also be able to consult the big doctors of the country!

“On the occasion of the 4th anniversary of Ayushman Bharat Health and Wellness Centres, ‘e-Sanjeevani Tele-consultation’ facility will be launched at 1 lakh centres on April 16. These centres are realising PM @NarendraModi ji’s resolve of ‘Ayushman Bharat’,” Mandaviya said in a tweet in Hindi on Friday.

As many as 1,17,440 AB-HWCs had been operationalised across the country by the end of March against the target of 1.1 lakh, according to the health ministry.

  • Related Posts

    WHO launches new primary health care course to strengthen health systems globally

    Health is a human right – yet not everyone can access the health services they need, when and where they need them, without financial hardship. Primary health care (PHC) provides…

    Ayurveda needs stronger evidence, safety monitoring for market adoption, says CCRAS

    Bengaluru: The Central Council for Research in Ayurvedic Sciences (CCRAS) has called for stronger scientific evidence, safety monitoring and translation of research into market-ready technologies to improve the credibility and…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    WHO launches new primary health care course to strengthen health systems globally

    WHO launches new primary health care course to strengthen health systems globally

    Ayurveda needs stronger evidence, safety monitoring for market adoption, says CCRAS

    Ayurveda needs stronger evidence, safety monitoring for market adoption, says CCRAS

    Yashoda Medicity Successfully Performs High-Risk Kidney Transplant in 28-Year- Old Woman

    Yashoda Medicity Successfully Performs High-Risk Kidney Transplant in 28-Year- Old Woman

    Avacta delivers two clinical stage peptide-drug conjugates to target delivery of toxic payloads into the tumour microenvironment

    Avacta delivers two clinical stage peptide-drug conjugates to target delivery of toxic payloads into the tumour microenvironment

    US FDA approves first gene therapy for paediatric patients with Sanfilippo syndrome type A

    US FDA approves first gene therapy for paediatric patients with Sanfilippo syndrome type A

    Technology and accessibility are key to growth of advanced treatment of heart diseases, says expert

    Technology and accessibility are key to growth of advanced treatment of heart diseases, says expert